Woburn, MA, United States of America

Jeffrey S Thompson


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jeffrey S. Thompson

Introduction

Jeffrey S. Thompson is a notable inventor based in Woburn, MA (US). He has made significant contributions to the field of medical science, particularly in the development of novel therapeutic agents. His work focuses on addressing critical health issues related to thrombotic diseases.

Latest Patents

Thompson holds a patent for "Bifunctional inhibitors of thrombin and platelet activation." This invention relates to innovative bifunctional inhibitors that target both platelet activation and thrombin. These inhibitors are characterized by two distinct domains: a glycoprotein IIb/IIIa inhibitory domain and a thrombin inhibitory domain. The patent also encompasses DNA sequences that encode these bifunctional inhibitors, recombinant DNA molecules containing these sequences, and hosts transformed with these DNA molecules. Furthermore, the invention details methods for purifying the recombinant bifunctional inhibitors and provides compositions that may be beneficial for treating thrombotic diseases.

Career Highlights

Thompson is associated with Biogen, Incorporated, where he applies his expertise in the development of medical innovations. His work has the potential to improve patient outcomes by increasing reocclusion time, decreasing reperfusion time, and inhibiting malignant cell growth.

Collaborations

Thompson has collaborated with esteemed colleagues such as John M. Maraganore and Betty H. Chao. These partnerships have likely contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Jeffrey S. Thompson's contributions to the field of medical science through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of thrombotic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…